|
|
|
Volumn 24, Issue 4, 1997, Pages 429-439
|
|
Combined modality therapy of non-small cell lung cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMIFOSTINE;
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EPIRUBICIN;
ETOPOSIDE;
FLUOROURACIL;
HYDROXYUREA;
IFOSFAMIDE;
LOMUSTINE;
MITOMYCIN C;
NAVELBINE;
PACLITAXEL;
TIOGUANINE;
VINBLASTINE;
VINDESINE;
BONE MARROW TOXICITY;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER STAGING;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTINUOUS INFUSION;
ESOPHAGITIS;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG NON SMALL CELL CANCER;
LUNG RESECTION;
MULTIMODALITY CANCER THERAPY;
ORAL DRUG ADMINISTRATION;
PNEUMONIA;
POSTOPERATIVE CARE;
PREOPERATIVE TREATMENT;
PRIORITY JOURNAL;
REVIEW;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
HUMANS;
LUNG NEOPLASMS;
SURVIVAL RATE;
|
|
EID: 0030738167
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (45)
|
|
References (110)
|
